Guest guest Posted January 3, 2003 Report Share Posted January 3, 2003 That study sounds like an late Phase I or early Phase II study; one dose to show if it does anything in people with a disease. It's promising, but too early to say if it either safe or effective. We'll have to keep our eyes and ears open to see if Biogen tries it on folks with our disease. Unfortunately, Biogen has recently cut back on their research because of money problems. Aubrey Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.